abstract |
The present invention relates to methods of treating tumors with VEGFR inhibitors. Specifically, the present invention relates to the use of a VEGFR inhibitor in the preparation of a medicament for treating tumors, wherein the VEGFR inhibitor is selected from VEGFR-2 inhibitors such as tafitinib, conitinib, and apatinib. |